Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Completed · Phase 2

Conditions studied: Lymphoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of etoposide in treating patients with relapsed non-Hodgkin's lymphoma.

Key facts

Study ID

NCT00002880

Run by

Alliance for Clinical Trials in Oncology

People needed

53

Starts

1996-11-01

Expected to finish

2008-01-01

Last updated by the study team

2016-06-28

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Minnesota Cancer Center — Minneapolis, Minnesota, United States
• Washington University Barnard Cancer Center — St Louis, Missouri, United States
• St. Joseph's Hospital and Medical Center — Paterson, New Jersey, United States
• Comprehensive Cancer Center of Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.